Table 1.
POIs | Techs | Advantages | Disadvantages |
---|---|---|---|
Intracellular proteins | PROTAC | Clear mechanisms of action 49; event-driven action 50; catalytic degradation activity 51; |
Limitation to cytosolic domain of proteins 36; In a proteasome-dependent manner 45; Poor cellular penetration needs to be solved 36 |
AUTAC | Targeting organelles and intracellular proteins; selective autophagy 11,39 |
Degradation mechanisms need further investigation 11,39 | |
ATTEC | Low molecular weight; selective degradation; Drug-like property 12 |
Hard to design 12 | |
Extracellular and membrane-bound proteins | LYTAC | Targeting extracellular and membrane-bound proteins 21; high selectivity in POIs and cell types 23,24 |
Poor tissue permeability 21; Complex synthesis of LTR ligands M6Pn 21; Possible immune response in vivo 52; Lack of studies |
AbTAC | Targeting membrane proteins; high bispecificity 22 |
High cost; Potential immunogenicity 53; Unclear endocytosis mechanism 22 |